Please assess the completion status of the following clinical trial:

Trial Title: DESolve® X-Pand Global Post Market Registry

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Minimal age 18 years~2. Patient is willing/able to cooperate with study procedures and required follow up visits. Patient or legal representative has been informed \& agrees by signing EC approved written consent. Consent can occur before implantation of the DESolve scaffold (planned procedure) or within 30 days post implantation procedure for retrospective enrollment (unplanned procedure).~3. Planned or unplanned DESolve scaffold implantation~Exclusion Criteria:~None

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PTCA - Desolve Scaffold (Type: None): Patients with coronary artery stenosis who have been treated with a DESolve bioresorbable coronary scaffold

Based on this trial design, predict the completion outcome and termination type (if applicable).